Algo version: 0.98b
Xiamen Amoytop Biotech is listed at the SHH Exchange
Xiamen Amoytop Biotech [688278.SS]
SHH Sector: Healthcare Industry:Biotechnology

Is Xiamen Amoytop Biotech stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Xiamen Amoytop Biotech pays dividends. Last time was Thursday 23rd of May 2024 where the investors holding the stock on Thursday 23rd of May 2024 were paid CNY0.41 per share. Over the last 5 times between 2020 and 2024, Xiamen Amoytop Biotech has paid CNY0.798 with an average of CNY0.16 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Xiamen Amoytop Biotech 10 years ago, but if you had invested on Friday 17th of January 2020 when the price was CNY35.30, you would have made a profit of CNY18.52 per share or 52.46%

Yes, the average daily trading liquidity for Xiamen Amoytop Biotech is CNY1.63 million. You should therefore be able to get in and out of your positions relatively fast.

Xiamen Amoytop Biotech has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 75.60, the company's ability to pay off the debt is good. Xiamen Amoytop Biotech has a very good net profit margin of 26.95% and should have very high tolerances against inflation.

We have calculated the inflation risk for Xiamen Amoytop Biotech to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.